USPTO serial 76369476
GENE CHOICE
Reviewed by CopyMark Law Group
Reg. 2749520Status 710
- Filing date
- Status date
- Registration date
- Aug 12, 2003
- Examiner
- HOWARD, CHERYL L
- Law office
- SCANNING ON DEMAND
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with GENE CHOICE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
FREDERICK, MD
Frederick, MD
Frederick, MD
Frederick, MD
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Susan A. Richards, Esq.
SUSAN A RICHARDS ESQ MILES & STOCKBRIDGE, PC1751 PINNACLE DR STE 500MCLEAN, VA 22010UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | full line of Molecular Biology Kits and Reagents for Genetic Research including, DNA Polymerase; DNA Polymerase Reaction Buffers in the nature of buffers used for amplification of DNA; Reaction mixes for running Polymerase Chain Reactions comprising DNA Polymerase, dNTP and Red Dye; DNA Polymerase, namely, Enzymes with DNA Polymerase and Proof-reading Exonnuclease activities; Buffer Optimization Kits comprising standard buffers, ammonium buffers and combination buffers used for finding optimal solutions for Polymerase Chain Reactions; Enhancer Optimization Kits for selecting additives for templates comprising reactions of enhancer solutions for testing to determine improvements in Polymerase Chain Reactions; Nucleotides; dNTP Mixes; dNTP Solutions for use in DNA polymerization reactions, DNA-labelling and sequencing processes; DNA ladders; Rapid Ligation Kits for Cloning or splicing DNA comprising ligase, ATP, and buffers; Cells, Restriction enzymes used for [cuffing] * cutting * DNA; Restriction endonucleases used for cutting DNA; RNA from specific tissue; Diethyl Pyrocarbonate Treated Water; Thermostable Reverse Transcriptase for making cDNA; Ribonuclease Inhibitors for preventing proteins from degrading RNA; Reverse Transcriptase Kits for purifying cDNA comprising buffers, reverse transcriptase and primers for allowing copying of RNA into DNA; Modifying Enzymes for modifying DNA; DNA Labelling Kits comprising DNA polymerase, Random Hexamers, Nucleotide Mixes and Reaction Buffers for allowing downstream identification of DNA; Plasmid Purification Spin Kits for purifying plasma DNA comprising resins, centrifuge tubes or containers, and buffers for allowing isolation of plasma DNA from bacteria; Genomic DNA Spin Kits comprising resins, centrifuge tubes or containers, and buffers for allowing isolation of DNA from cells; DNA Blood Spin Kits comprising resins, centrifuge tubes or containers, and buffers for [allowaing] * allowing * isolation of DNA from blood; DNA or RNA Isolation Kits for extracting genomic DNA or RNA from whole blood, blood lymphocytes, cultured cells or tissues, comprising resins, columns and buffers for allowing isolation of DNA or RNA from cells or tissue; Kits for Recovering DNA fragments from gels or solutions comprising resins and buffers for isolating DNA from agrose gel; Kits for purification of PCR products or DNA comprising PCR assay, buffers and spin filters for isolating DNA from Polymerase Chain Reactions; Spin columns for isolating DNA or RNA; Kits for isolating RNA free of genomic DNA comprising resins, columns and buffers for allowing isolation of RNA from cells or tissue; Kits for isolating RNA from a variety of samples comprising resins, columns and buffers for allowing isolation of RNA from cells or tissue; Kits for isolating RNA from plant material comprising resins, columns, and buffers for allowing isolation of RNA from plant tissue; and Reagents | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by KEMP BIOTECHNOLOGIES, INC.
- Other trademarks owned by GeneChoice, Inc.
- Other trademarks owned by GeneChoice, Inc.
- Other trademarks owned by GeneChoice, Inc.
- Other trademarks in Class 009
- Similar marks named GENE CHOICE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 14, 2010 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jul 24, 2008 | CFIT | CASE FILE IN TICRS | — |
| Apr 4, 2007 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Nov 5, 2003 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Sep 8, 2003 | AMD7 | SEC 7 REQUEST FILED | — |
| Sep 8, 2003 | PAPER RECEIVED | — | |
| Aug 12, 2003 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 20, 2003 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 30, 2003 | NPUB | NOTICE OF PUBLICATION | — |
| Mar 6, 2003 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 3, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 3, 2003 | PAPER RECEIVED | — | |
| Dec 20, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 20, 2002 | PAPER RECEIVED | — | |
| Jun 20, 2002 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 5, 2002 | DOCK | ASSIGNED TO EXAMINER | — |